{
  "meta": {
    "title": "Sedative_Hypnotics",
    "url": "https://brainandscalpel.vercel.app/sedative-hypnotics-21c98558.html",
    "scrapedAt": "2025-11-29T18:33:51.175Z"
  },
  "questions": [
    {
      "id": 14557,
      "choices": [
        {
          "id": 58189,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertrophy of gums </span></span></span></p>"
        },
        {
          "id": 58190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hirsutism </span></span></span></p>"
        },
        {
          "id": 58191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypertension </span></span></span></p>"
        },
        {
          "id": 58192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersensitivity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old male patient with a history of epilepsy presents to your clinic. He has been taking phenytoin for several years to control his seizures. Which of the following is not an adverse effect of phenytoin?</span></span></span></p>",
      "unique_key": "Q3497293",
      "question_audio": null,
      "question_video": null,
      "map_id": 36161,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypertension</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Phenytoin</strong> is an <strong>antiepileptic medication </strong>that is commonly <strong>used to treat seizures. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can <strong>cause several adverse effects</strong>, including:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Hypertrophy of gums</strong>: <strong>Phenytoin</strong> can <strong>cause overgrowth of the gum tissue</strong>, leading to a condition known as <strong>gingival hyperplasia.</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Hirsutism: Phenytoin</strong> can cause<strong> excessive hair growth</strong>, particularly in<strong> women.</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Hypersensitivity: Phenytoin</strong> can cause an<strong> allergic reaction</strong> in some patients, leading to symptoms such as <strong>rash, fever, and swollen lymph nodes.</strong></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, <strong>hypertension</strong> is <strong>not </strong>a common adverse effect of<strong> phenytoin.</strong> It can cause <strong>cardiovascular effects</strong> such as <strong>hypotension and arrhythmias</strong>, but<strong> not hypertension.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adverse effects of phenytoin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">H</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Hirsutism</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertrophy of gums</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Osteomalacia</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Teratogenicity</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">M</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Megaloblastic anemia</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Ataxia and nystagmus</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">L</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Lymphadenopathy</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> &ndash; Inhibits insulin release (Hyperglycemia)<br />\r\n<strong>K</strong> &ndash; Vit K deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A </span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ndash; Arrhythmias </span></span></p>",
      "correct_choice_id": 58191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14455,
      "choices": [
        {
          "id": 57781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vigabatrin decreases GABA uptake at the synaptic cleft. </span></span></span></p>"
        },
        {
          "id": 57782,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vigabatrin increases GABA uptake at the synaptic cleft. </span></span></span></p>"
        },
        {
          "id": 57783,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Vigabatrin is a GABA transaminase inhibitor.</span></span></span></p>"
        },
        {
          "id": 57784,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vigabatrin is a GABA transacetylase inhibitor.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old patient is present to the clinic with a history of seizures. The patient is diagnosed with epilepsy and started on vigabatrin therapy. Which of the following statements is true about vigabatrin?</span></span></span></p>",
      "unique_key": "Q8601060",
      "question_audio": null,
      "question_video": null,
      "map_id": 36159,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. C) Vigabatrin is a GABA transaminase inhibitor.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Vigabatrin</strong> is an<strong> antiepileptic drug </strong>effective in the treatment of<strong> partial seizures and infantile spasms</strong>. It functions by <strong>inhibiting GABA</strong> <strong>transaminase, </strong>an enzyme responsible for the <strong>breakdown of GABA.</strong> By <strong>inhibiting this enzyme</strong>,<strong> vigabatrin increases the concentration</strong> of<strong> GABA in the brain,</strong> <strong>enhancing</strong> its<strong> inhibitory effect on neuronal activity</strong>, which is crucial for<strong> controlling seizures.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Decreases GABA uptake at the synaptic cleft:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect</strong>, vigabatrin <strong>does not</strong> decrease GABA uptake; it<strong> increases GABA</strong> availability by<strong> inhibiting its breakdown.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increases GABA uptake at the synaptic cleft:&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Incorrect</strong>,<strong> vigabatrin&#39;s</strong> mechanism <strong>does not</strong> involve<strong> altering GABA uptake</strong> <strong>mechanisms directly.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. GABA transacetylase inhibitor:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect,</strong> as there is <strong>no enzyme</strong> known as<strong> GABA transacetylase </strong>involved in<strong> GABA</strong> <strong>metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Vigabatrin </strong>effectively treats <strong>seizures</strong> by <strong>inhibiting GABA transaminase, </strong>thereby <strong>increasing the inhibitory neurotransmitter GABA</strong> in the<strong> brain</strong>, crucial for<strong> reducing excessive neuronal firing </strong>associated <strong>with epilepsy.</strong> Additionally, it is the <strong>drug of choice </strong>for <strong>infantile</strong> <strong>spasms</strong> related to<strong> tuberous sclerosis</strong>, but<strong> potential side effects</strong> include<strong> irreversible visual field defects and behavioral changes.</strong></span></span></span></p>",
      "correct_choice_id": 57783,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14467,
      "choices": [
        {
          "id": 57829,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Barbiturate</span></span></span></p>"
        },
        {
          "id": 57830,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 57831,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Protamine sulphate</span></span></span></p>"
        },
        {
          "id": 57832,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flumazenil</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following drugs can be used in benzodiazepine toxicity? </span></span></span></p>",
      "unique_key": "Q4060972",
      "question_audio": null,
      "question_video": null,
      "map_id": 36157,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Flumazenil</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Flumazenil&nbsp;</span></strong><span style=\"font-size:12.0pt\">is an<strong> antagonist of the benzodiazepine receptor </strong>and is used to<strong> reverse the effects of benzodiazepines</strong> in cases of <strong>overdose or toxicity. </strong>It can <strong>rapidly reverse the sedation and respiratory depression</strong> that may occur with <strong>benzodiazepine overdose.</strong> <strong>Flumazenil </strong>is administered<strong> intravenously </strong>and is <strong>used in emergency settings </strong>where <strong>benzodiazepine overdose is suspected.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Barbiturate</span></strong><span style=\"font-size:12.0pt\">: Barbiturates act on the <strong>central nervous system </strong>similarly to <strong>benzodiazepines </strong>but through <strong>different</strong> <strong>mechanisms. </strong>They <strong>would not reverse benzodiazepine toxicity</strong> and could potentially <strong>worsen central nervous system depression</strong> if <strong>used together.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ethyl alcohol</span></strong><span style=\"font-size:12.0pt\">: Ethanol (ethyl alcohol) was used as an<strong> antidote for methanol poisoning</strong> (now the <strong>drug of choice</strong> is <strong>fomepizole)</strong>. It has<strong> no role</strong> in the treatment of<strong> benzodiazepine toxicity</strong> and could potentially<strong> lead to further central nervous system depression.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Protamine sulphate</span></strong><span style=\"font-size:12.0pt\">: Protamine sulphate is used to<strong> reverse the effects of heparin, an anticoagulant, </strong>and has <strong>no </strong>role in treating<strong> benzodiazepine toxicity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key <strong>educational takeaway</strong> is to <strong>recognize flumazenil </strong>as the <strong>specific antidote for benzodiazepine toxicity.</strong> Antidotes of <strong>different toxicities</strong> is <strong>very important</strong> to remember for<strong> entrance exams. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IMPORTANT ANTIDOTES</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-134937.jpg\" style=\"height:1091px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 57832,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14477,
      "choices": [
        {
          "id": 57869,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amantadine causes ankle edema.</span></span></span></p>"
        },
        {
          "id": 57870,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levodopa is effective in reducing tremors.</span></span></span></p>"
        },
        {
          "id": 57871,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amantadine is more effective than levodopa.</span></span></span></p>"
        },
        {
          "id": 57872,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anti-muscarinic agents are effective in drug induced Parkinsonism.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mr. PL Sharma, a 60-year-old man with a history of Parkinson&#39;s disease, presents to hospital with complaints of tremors and difficulty walking. He is currently taking levo-dopa. He asks about other treatment options with his doctor. Which of the following statements is False regarding drugs used in the treatment of Parkinsonism? </span></span></span></p>",
      "unique_key": "Q7392664",
      "question_audio": null,
      "question_video": null,
      "map_id": 36158,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Amantadine is more effective than levodopa.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Levo-dopa plus carbi-dopa</strong> combination is<strong> most effective drug </strong>in treatment of <strong>Parkinsonism</strong></span><span style=\"font-size:12.0pt\">, known for significantly <strong>reducing</strong> <strong>symptoms </strong>such as<strong> tremors, rigidity, and bradykinesia</strong>.<strong> Amantadine</strong>, while <strong>useful for </strong>some symptoms and known to cause side effects like<strong> ankle edema and livedo reticularis</strong>, <strong>does not</strong> <strong>surpass levodopa in effectiveness</strong>. <strong>Anti-muscarinic agents </strong>are indeed <strong>helpful</strong> in managing<strong> drug-induced Parkinsonism, </strong>which occurs <strong>due to dopamine blockade </strong>from<strong> other medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>True, amantadine</strong> can cause <strong>ankle edema</strong> among <strong>other side effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>True</strong>,<strong> levodopa</strong> is<strong> well-known</strong> for <strong>its efficacy </strong>in<strong> reducing Parkinsonian tremors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>True</strong>, <strong>anti-muscarinic agents </strong>help relieve <strong>symptoms of Parkinsonism</strong>, especially when caused by the <strong>use of drugs</strong> like <strong>antipsychotics.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Levodopa</strong> remains the <strong>cornerstone of Parkinson&#39;s disease </strong>treatment <strong>due to its superior effectiveness</strong> in<strong> reducing</strong> the core <strong>symptoms </strong>of the<strong> disorder</strong>, whereas <strong>amantadine, though beneficial,</strong> is<strong> less effective</strong></span></span></p>",
      "correct_choice_id": 57871,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14497,
      "choices": [
        {
          "id": 57949,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Piracetam </span></span></span></p>"
        },
        {
          "id": 57950,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Edaravone </span></span></span></p>"
        },
        {
          "id": 57951,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ceftriaxone </span></span></span></p>"
        },
        {
          "id": 57952,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Doxycycline</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 54-year-old male presents to the clinic with symptoms of muscle weakness, twitching, and difficulty speaking. He is diagnosed with Amyotrophic Lateral Sclerosis (ALS). The patient is started on a new medication that has been shown to slow the decline of physical function in individuals with ALS. Which of the following is recently approved for the treatment of ALS? </span></span></span></p>",
      "unique_key": "Q6268921",
      "question_audio": null,
      "question_video": null,
      "map_id": 36156,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Edaravone. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Edaravone,</strong> a<strong> free radical scavenger, </strong>has been approved for use in the treatment of<strong> ALS</strong> and is known to <strong>slow the progression of</strong> <strong>physical decline</strong> in patients with this condition. It functions by<strong> mitigating oxidative stress</strong>, which is believed to be a factor in the <strong>neuronal damage </strong>associated with<strong> ALS. Edaravone</strong> is <strong>administered intravenously,</strong> typically in treatment cycles that involve <strong>daily</strong> <strong>infusions</strong> for <strong>specific periods</strong> followed by <strong>drug-free intervals.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Piracetam:</span></strong><span style=\"font-size:12.0pt\"> While used for <strong>cognitive enhancement </strong>in some neurological conditions, it is <strong>not </strong>approved for<strong> treating ALS</strong> and <strong>does not </strong>address the <strong>motor neuron degeneration </strong>typical of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span style=\"font-size:12.0pt\"> This <strong>antibiotic</strong> has been explored in research settings for<strong> potential benefits in ALS</strong> due to its<strong> neuroprotective</strong> <strong>properties</strong> in <strong>animal models,</strong> but it is <strong>not</strong> approved for this use pending further clinical trials.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Doxycycline:</span></strong><span style=\"font-size:12.0pt\"> An<strong> antibiotic</strong> with <strong>no approval</strong> or <strong>substantial evidence </strong>supporting its <strong>use in treating ALS.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Edaravone</strong> represents a significant advancement in the <strong>management of ALS </strong>by specifically<strong> targeting oxidative stress</strong>, providing hope for potentially <strong>slowing the disease&#39;s progression</strong>. This drug&#39;s role in<strong> ALS treatment</strong> <strong>underscores</strong> the importance of <strong>antioxidant</strong> therapy in<strong> neurodegenerative diseases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Important Drugs Used in Treatment of ALS</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-150505.jpg\" style=\"height:403px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 57950,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14619,
      "choices": [
        {
          "id": 58437,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stop imipramine and start valproate.</span></span></span></p>"
        },
        {
          "id": 58438,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Add Benzodiazepine to imipramine.</span></span></span></p>"
        },
        {
          "id": 58439,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Add antipsychotic to imipramine. </span></span></span></p>"
        },
        {
          "id": 58440,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start selective serotonin reuptake inhibitor.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient was presented with symptoms of depression and was started with imipramine. Post-treatment, he develops symptoms of excessive energy, elated mood and lack of sleep, excessive cheerfulness, and talkativeness. What should be the modification in the treatment? </span></span></span></p>",
      "unique_key": "Q3854389",
      "question_audio": null,
      "question_video": null,
      "map_id": 36160,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Stop imipramine and start valproate.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>patient&#39;s presentation</strong> after <strong>initiating treatment</strong> with <strong>imipramine</strong>, a <strong>tricyclic</strong> <strong>antidepressant (TCA),</strong> suggests a <strong>switch to manic symptoms</strong>, characterized by <strong>excessive</strong> <strong>energy, elated mood, lack of sleep, excessive cheerfulness, and talkativeness</strong>. This change in clinical presentation may <strong>indicate bipolar disorder, </strong>where the patient experiences<strong> episodes</strong> <strong>of depression</strong> as well as<strong> mania or hypomania.</strong> In such cases, the <strong>use of antidepressants</strong> alone, especially <strong>TCAs like imipramine,</strong> can precipitate <strong>manic episodes </strong>or <strong>rapid cycling</strong> between <strong>mood states. </strong>The appropriate <strong>modification in treatment </strong>involves <strong>discontinuing</strong> the <strong>antidepressant</strong> that may contribute to the <strong>manic switch and initiating a mood stabilizer.</strong> <strong>Valproate</strong> is a<strong> mood stabilizer</strong> that is effective in <strong>managing and preventing manic episodes</strong>, making it a<strong> suitable choice for this patient.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Add benzodiazepines to imipramine:</span></strong><span style=\"font-size:12.0pt\"> While benzodiazepines can be useful for managing <strong>acute anxiety or agitation,</strong> they do<strong> not</strong> address the underlying <strong>mood dysregulation</strong> seen in <strong>bipolar disorder</strong>. Adding a<strong> benzodiazepine to imipramine</strong> <strong>would not</strong> <strong>prevent future manic episodes </strong>and could potentially <strong>complicate </strong>the <strong>clinical picture</strong> with <strong>dependency or withdrawal issues.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Add antipsychotic to imipramine:</span></strong><span style=\"font-size:12.0pt\"><strong> Adding an antipsychotic</strong> can be an <strong>appropriate</strong> <strong>intervention for managing acute mania or psychosis.</strong> However, <strong>without</strong> <strong>discontinuing the</strong> <strong>antidepressant</strong> that potentially <strong>triggered the manic episode</strong>, this approach <strong>might not</strong> fully address the<strong> risk of future manic switches</strong>. Furthermore, for <strong>long-term management, focusing</strong> on <strong>mood stabilization is essential.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Start Selective Serotonin Reuptake Inhibitor:</span></strong><span style=\"font-size:12.0pt\"> <strong>Starting a </strong></span><span style=\"font-size:12.0pt\"><strong>Selective Serotonin</strong> <strong>Reuptake Inhibitor (SSRI) </strong>in a patient showing symptoms of<strong> mania could exacerbate manic</strong> <strong>symptoms</strong>. <strong>SSRIs,</strong> like <strong>TCAs</strong>, can<strong> precipitate manic episodes </strong>in patients with <strong>bipolar disorder.</strong> Therefore, this option <strong>would no</strong>t be appropriate for <strong>modifying the treatment </strong>in response to the<strong> emergence of manic symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational objective is to understand the management of <strong>mood disorders</strong>, particularly <strong>bipolar disorder</strong>, and the <strong>importance of identifying and treating manic symptoms </strong>that may <strong>emerge during antidepressant therapy.</strong> This <strong>scenario</strong> emphasizes the need for <strong>careful</strong> <strong>evaluation and modification of treatment</strong> in patients presenting with <strong>mania</strong>, highlighting the <strong>transition from antidepressants to mood stabilizers,</strong> such as<strong> valproate, </strong>for <strong>effective</strong> management of <strong>bipolar disorder.</strong></span></span></span></p>",
      "correct_choice_id": 58437,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}